CTLs- and lymphokine-induced apoptosis of infected hepatocytes during
the course of chronic viral hepatitis is thought to be important for b
oth disease termination and prevention of hepatocellular transformatio
n, We therefore studied apoptosis induced by Pas (APO-1 or CD95) - a w
idely expressed cell surface receptor whose ligand is involved in lymp
hocyte cytotoxicity - in a set of human hepatoma cell lines. As normal
hepatocytes, all of the human hepatoma cell lines tested do express d
etectable amounts of Fas on their surface. Nevertheless, only PLC/PRF/
5 cells undergo apoptosis following treatment with anti-Fas. Systemati
c cloning and sequence analysis of the Pas cDNA did not show mutations
in the Pas gene in any of the cells lines tested, However, due to alt
ernative splicing, 5 to 10% of the Fas cDNAs are deleted of 63 interna
l nucleotides corresponding to the transmembrane domain, thus encoding
for a soluble and secreted form of Fas (Fas Delta TM), potentially ab
le to neutralize anti-Fas or Fas-Ligand. Although we could not demonst
rate a direct correlation between resistance of different hepatoma cel
l lines to Pas mediated death and endogenous expression of this transc
ript, we show that PLC/PRF 5 stable transfectants overexpressing Fas D
elta TM are less sensitive to anti-Pas than control cells, Tn three di
fferent cell lines, resistance to anti-Pas was overcome by treatment w
ith the protein synthesis inhibitor cyclohexymide, Although this could
suggest the existence of short-lived repressors of the Fas-activated
apoptotic signalling pathway(s), we show that translational inhibition
is not required for the synergistic effect of cycloheximide to take p
lace, and that resistant hepatoma cells can be sensitized to anti-Pas
by subinhibitory concentrations of this protein synthesis inhibitor. S
ince cycloheximide is able to activate intracellular signalling indepe
ndently on its effects on protein sysnthesis, we suggest that it might
provide a costimulatory signal that cooperates with Fas in the induct
ion of cell death and that, at least in the cells we tested, resistanc
e to Fas is not an active process involving gene transciption and tran
slation but only the consequence of an inadequate apoptotic stimulatio
n.